Zhi Hong Chen
Direktor/Vorstandsmitglied bei Shanghai Neutan Pharmaceutical Co., Ltd.
Aktive Positionen von Zhi Hong Chen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Shanghai Neutan Pharmaceutical Co., Ltd.
Shanghai Neutan Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Neutan Pharmaceutical Co., Ltd. provides synthetic chemistry and customization services. Shanghai Neutan Pharmaceutical Co. is a national high-tech enterprise and a one-stop full-process innovative drug CDMO platform. The company is based in Shanghai, China. The Chinese company has established a complete quality assurance system that complies with domestic and international GMP standards. The company offers high-quality CMC, clinical samples, and commercial products. The company's business scope includes pre-clinical CRO, new drug discovery FTE, CMC, new drug discovery FFS, CXO, etc. The company was founded in 2019 by Xue Jun Liu, and the CEO is Xiao Dong Chen. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Zhi Hong Chen
Ehemalige bekannte Positionen von Zhi Hong Chen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - |
Statistik
International
China | 3 |
Operativ
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD | Health Technology |
Private Unternehmen | 1 |
---|---|
Shanghai Neutan Pharmaceutical Co., Ltd.
Shanghai Neutan Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Neutan Pharmaceutical Co., Ltd. provides synthetic chemistry and customization services. Shanghai Neutan Pharmaceutical Co. is a national high-tech enterprise and a one-stop full-process innovative drug CDMO platform. The company is based in Shanghai, China. The Chinese company has established a complete quality assurance system that complies with domestic and international GMP standards. The company offers high-quality CMC, clinical samples, and commercial products. The company's business scope includes pre-clinical CRO, new drug discovery FTE, CMC, new drug discovery FFS, CXO, etc. The company was founded in 2019 by Xue Jun Liu, and the CEO is Xiao Dong Chen. | Health Technology |
- Börse
- Insiders
- Zhi Hong Chen
- Erfahrung